$99.70 -0.58 (-0.58%) Intercept Pharmaceuticals Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 99.70
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: -0.58 (-0.58%)
Prev Close: 100.28
Open: 99.75
Bid: 99.70
Ask: 99.76
  1. Can-Fite An Emerging NASH Play With CF102

    TalkMarkets | Oct. 13, 2016 | 09:10AM EST
  2. 5 Biotech Stocks to Watch as Interest in NASH Increases

    TalkMarkets | Sep. 22, 2016 | 13:45PM EST
  3. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga | Feb. 16, 2016 | 04:22AM EST
  4. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 15, 2016 | 19:35PM EST
  5. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  6. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company Exploring A Potential Sale

    Benzinga | Feb. 12, 2016 | 13:43PM EST
  7. Benzinga's Top Upgrades

    Benzinga | Jan. 29, 2016 | 09:14AM EST
  8. BioMarin, Intercept hit by FDA

    IBD | Dec. 18, 2015 | 18:47PM EST
  9. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD | Dec. 18, 2015 | 12:13PM EST
  10. INTERCEPT PHARMA

    IBD | Dec. 17, 2015 | 19:25PM EST
  11. Intercept Pharma Higher On Takeover Rumor

    Benzinga | Dec. 15, 2015 | 14:08PM EST
  12. Intercept Presents New Data Analyses on Non-Invasive Liver Testing From FLINT Trial of Obeticholic Acid in Nonalcoholic Steatohepatitis at AASLD 2015

    Benzinga | Nov. 15, 2015 | 09:59AM EST
  13. Intercept Presents New Primary Biliary Cholangitis Data at AASLD 2015

    Benzinga | Nov. 15, 2015 | 09:57AM EST
  14. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga | Nov. 10, 2015 | 20:19PM EST
  15. Intercept Pharmaceuticals

    IBD | Oct. 28, 2015 | 17:47PM EST
Trading Center